SCHEMBL30825930

SCHEMBL30825930

Cn1c(=O)n(-c2ccc(Cl)nc2)c2ncc(C#N)cc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.42
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
GRM4 Q14833 1/20 0.36
MAOB P27338 1/20 0.35
BCL6 P41182 1/20 0.35
PTGER4 P35408 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
PIK3CA P42336 3/20 0.34
PRKDC P78527 3/20 0.34
TNKS O95271 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
MTOR P42345 2/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CG P48736 1/20 0.33
TDP2 O95551 1/20 0.33
GSK3B P49841 1/20 0.33
CYP11B2 P19099 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27252335 1.00 HSD17B10 (0.42) HSD17B10HPGDHTTGRM4MAOB
SCHEMBL29314306 0.87 PIK3CA (0.39) HSD17B10HPGDHTTGRM4MAOB
SCHEMBL27252258 0.84 JAK3 (0.39) BCL6MEN1KMT2AL3MBTL1PIK3CA
SCHEMBL27252269 0.84 TNKS (0.40) HSD17B10HPGDHTTGRM4BCL6
SCHEMBL27446467 0.84 HSD17B10 (0.35) HSD17B10HPGDHTTGRM4MAOB
SCHEMBL27252322 0.79 GSK3B (0.37) HSD17B10HPGDHTTBCL6MEN1
SCHEMBL27263578 0.78 PRKDC (0.46) PIK3CAPRKDCMTOR
SCHEMBL29311521 0.77 HSD17B10 (0.57) HSD17B10HPGDHTTMAOBBCL6
SCHEMBL30825851 0.76 USP14 (0.42) HSD17B10HPGDHTTGRM4MEN1
SCHEMBL27252120 0.76 USP14 (0.42) HSD17B10HPGDHTTGRM4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4590396-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF Astrazeneca AB (SE) 2025-07-30 EP disclosed
WO-2024062089-A1 PCSK9 INHIBITORS AND METHODS OF USE THEREOF ASTRAZENECA AB (SE) 2024-03-28 WO disclosed